MedVasc patented technology, Solutio catheter system enables pain-free & precise local anesthesia, supporting an existing $1B market.
MedVasc has raised $2.6M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
MedVasc's investors include Life Science Invest, LU Innovation, LU Holding, Unknown Investor.
MedVasc is headquartered in Lund, Sweden.
MedVasc patented technology, Solutio catheter system enables pain-free & precise local anesthesia, supporting an existing $1B market.
MedVasc is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MedVasc — Funding & Investors." VCBacked, January 28, 2026, https://www.vcbacked.co/company/medvasc. Accessed August 14, 2026.
VCBacked. (2026). MedVasc — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/medvasc
{{cite web |title=MedVasc — Funding & Investors |url=https://www.vcbacked.co/company/medvasc |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated